Hormones and Cancer

Hormones play a significant role in the development and progression of certain cancers. Hormone-sensitive cancers, such as breast, prostate, and ovarian cancers, rely on hormones like estrogen, progesterone, and testosterone to grow. For instance, in breast cancer, elevated estrogen levels can stimulate the growth of hormone receptor-positive tumors. Similarly, prostate cancer can be driven by testosterone. Understanding this relationship has led to targeted treatments, such as hormone therapies, which aim to block hormone production or receptor interactions to slow or halt cancer progression. These therapies can include medications like aromatase inhibitors for breast cancer or anti-androgens for prostate cancer. However, the effectiveness of hormone therapies varies among individuals, and not all cancers are hormone-dependent. Ongoing research continues to explore the complex interactions between hormones and cancer to develop more precise and effective treatments.

    Related Conference of Hormones and Cancer

    September 23-24, 2024

    5th Global Summit on Environmental Health

    Amsterdam, Netherlands
    October 14-15, 2024

    3rd World Congress on Climate change and Ecosystem

    Madrid, Spain
    November 28-29, 2024

    19th World Convention on Waste Recycling and Reuse

    Aix-en-Provence, France
    February 13-14, 2025

    4th World Congress on Endocrinology & Diabetes

    Rome, Italy
    February 24-25, 2025

    4th World Congress on Sustainable Waste Management

    Madrid, Spain
    April 14-15, 2025

    13th World Conference on Climate Change

    Aix-en-Provence, France
    June 16-17, 2025

    20th World Bioenergy Congress and Expo

    Frankfurt, Germany
    August 26-27, 2025

    13th International Conference on Green Energy

    Paris, France

    Hormones and Cancer Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in